Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 194 entries
View as:

The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT01043068 Org: User:
Start: 01/31/10 End: 12/31/10 Due: 12/31/11

A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT01829035 Org: User:
Start: 02/21/13 End: 06/21/17 Due: 06/21/18

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03756298 Org: User:
Start: 01/15/19 End: 01/31/27 Due: 01/31/28

Preoperative Nutritional Support in Malnutritional Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02626195 Org: User:
Start: 10/31/13 End: 04/05/17 Due: 04/05/18

Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT01730677 Org: User:
Start: 07/31/12 End: 12/31/17 Due: 12/31/18

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT03062072 Org: User:
Start: 04/30/15 End: 12/31/22 Due: 12/31/23

Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases

Phase: N/A Priority: Normal
NCT ID: NCT02421432 Org: User:
Start: 12/01/17 End: 12/01/22 Due: 12/01/23

Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00980603 Org: User:
Start: 11/30/08 End: 05/31/11 Due: 05/31/12

Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06135896 Org: User:
Start: 01/16/24 End: 06/30/26 Due: 06/30/27

Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00532285 Org: User:
Start: 09/30/05 End: 08/31/09 Due: 08/31/10

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02488603 Org: User:
Start: 08/31/15 End: - Due: -

Combination Method Using Sodium Picosulfate and Magnesium Citrate and PEG With Ascorbic Acid for Bowel Preparation

Phase: N/A Priority: Normal
NCT ID: NCT02979223 Org: User:
Start: 11/30/16 End: 06/30/17 Due: 06/30/18

Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04203849 Org: User:
Start: 07/03/19 End: 06/30/34 Due: 06/30/35

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00506168 Org: User:
Start: 11/30/01 End: 07/31/07 Due: 07/31/08

A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00980382 Org: User:
Start: 09/30/04 End: 08/31/07 Due: 08/31/08

Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)

Phase: N/A Priority: Normal
NCT ID: NCT01587534 Org: User:
Start: 10/31/11 End: 12/31/14 Due: 12/31/15

Cross-sectional and Questionnaire Study for Leg Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT02069171 Org: User:
Start: 06/30/12 End: 11/30/12 Due: 11/30/13

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03755141 Org: User:
Start: 12/15/18 End: 06/30/22 Due: 06/30/23

Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01527396 Org: User:
Start: 12/31/11 End: 08/31/15 Due: 08/31/16

Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00980759 Org: User:
Start: 07/28/06 End: 12/31/24 Due: 12/31/25

Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02395523 Org: User:
Start: 03/05/15 End: 05/18/20 Due: 05/18/21

Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation

Phase: N/A Priority: Normal
NCT ID: NCT02551198 Org: User:
Start: 11/01/15 End: 09/01/17 Due: 09/01/18

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00398385 Org: User:
Start: 05/31/05 End: - Due: -

Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan

Phase: N/A Priority: Normal
NCT ID: NCT04984174 Org: User:
Start: 08/04/21 End: 12/28/24 Due: 12/28/25

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06388720 Org: User:
Start: 11/19/24 End: 12/31/27 Due: 12/31/28